Vés al contingut

Phase 3 randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy and safety of nipocalimab in pregnancies at risk for severe hemolyticdisease of the fetus and newborn (hdfn) - azalea

Obert
  • Codi protocol: 80202135EBF3001
  • Codi EudraCT: No aplica
  • Grup de recerca: Medicina Materna i Fetal
  • Servei: Obstetrícia
  • Investigador/a principal:  Sánchez Durán, Maria Ángeles
  • Malaltia: Embaràs, part i puerperi
  • Fase: Fase III